First, the Oncomine database analysis revealed that higher PDLIM3 mRNA expression was found in esophageal, brain and CNS, kidney, gastric, pancreatic, liver cancer, lymphoma, and sarcoma, while breast, bladder, head and neck, colorectal, lung, kidney, prostate, ovarian cancer, lymphoma, and sarcoma exhibited lower levels. This evidence concerns the gene PDLIM3 and sarcoma.